Elevance Health, Inc. (ELV) stock
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3011% below fair value
$433.93−12.35 (-2.77%)
Close on Nov 17, 2026Market cap $93.75BP/E 18.5Yield –
Elevance Health total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Elevance Health's total debt was $30.76B at Sep 30, 2026. For fiscal 2025 it was $32.05B, up 2.6% from the year before. Over ten years it grew 7.3% a year on average. The highest annual figure on record is $32.05B in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.05B | +2.6% |
| FY2024 | Dec 31, 2024 | $31.23B | +24.3% |
| FY2023 | Dec 31, 2023 | $25.12B | +4.2% |
| FY2022 | Dec 31, 2022 | $24.11B | +4.7% |
| FY2021 | Dec 31, 2021 | $23.03B | +15.0% |
| FY2020 | Dec 31, 2020 | $20.04B | -0.2% |
| FY2019 | Dec 31, 2019 | $20.09B | +4.5% |
| FY2018 | Dec 31, 2018 | $19.21B | -3.6% |
| FY2017 | Dec 31, 2017 | $19.93B | +26.7% |
| FY2016 | Dec 31, 2016 | $15.73B | -0.9% |
| FY2015 | Dec 31, 2015 | $15.86B | +5.5% |
| FY2014 | Dec 31, 2014 | $15.04B | +3.8% |
| FY2013 | Dec 31, 2013 | $14.49B | -3.2% |
| FY2012 | Dec 31, 2012 | $14.98B | +52.2% |
| FY2011 | Dec 31, 2011 | $9.84B | +9.9% |
| FY2010 | Dec 31, 2010 | $8.95B | +6.6% |
| FY2009 | Dec 31, 2009 | $8.40B | -5.0% |
| FY2008 | Dec 31, 2008 | $8.84B | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $30.76B | -4.2% |
| Q2 FY2026 | Jun 30, 2026 | $31.04B | +2.8% |
| Q1 FY2026 | Mar 31, 2026 | $31.84B | +6.1% |
| Q4 FY2025 | Dec 31, 2025 | $32.05B | +2.6% |
| Q3 FY2025 | Sep 30, 2025 | $32.10B | +18.2% |
| Q2 FY2025 | Jun 30, 2025 | $30.19B | +9.0% |
| Q1 FY2025 | Mar 31, 2025 | $30.00B | +13.4% |
| Q4 FY2024 | Dec 31, 2024 | $31.23B | +24.3% |
| Q3 FY2024 | Sep 30, 2024 | $27.15B | +9.3% |
| Q2 FY2024 | Jun 30, 2024 | $27.69B | +10.2% |
| Q1 FY2024 | Mar 31, 2024 | $26.45B | +3.9% |
| Q4 FY2023 | Dec 31, 2023 | $25.12B | +4.2% |
| Q3 FY2023 | Sep 30, 2023 | $24.84B | +4.5% |
| Q2 FY2023 | Jun 30, 2023 | $25.12B | +6.5% |
| Q1 FY2023 | Mar 31, 2023 | $25.47B | +9.5% |
| Q4 FY2022 | Dec 31, 2022 | $24.11B | +4.7% |
| Q3 FY2022 | Sep 30, 2022 | $23.77B | +4.3% |
| Q2 FY2022 | Jun 30, 2022 | $23.59B | +1.5% |
| Q1 FY2022 | Mar 31, 2022 | $23.26B | +0.1% |
| Q4 FY2021 | Dec 31, 2021 | $23.03B | +15.0% |
| Q3 FY2021 | Sep 30, 2021 | $22.79B | +9.3% |
| Q2 FY2021 | Jun 30, 2021 | $23.24B | +8.2% |
| Q1 FY2021 | Mar 31, 2021 | $23.23B | +7.2% |
| Q4 FY2020 | Dec 31, 2020 | $20.04B | -0.2% |
| Q3 FY2020 | Sep 30, 2020 | $20.84B | +3.0% |
| Q2 FY2020 | Jun 30, 2020 | $21.48B | +11.3% |
| Q1 FY2020 | Mar 31, 2020 | $21.68B | +12.1% |
| Q4 FY2019 | Dec 31, 2019 | $20.09B | +4.5% |
| Q3 FY2019 | Sep 30, 2019 | $20.23B | +4.2% |
| Q2 FY2019 | Jun 30, 2019 | $19.30B | +0.1% |
| Q1 FY2019 | Mar 31, 2019 | $19.34B | -2.7% |
| Q4 FY2018 | Dec 31, 2018 | $19.21B | -3.6% |
| Q3 FY2018 | Sep 30, 2018 | $19.42B | +19.6% |
| Q2 FY2018 | Jun 30, 2018 | $19.29B | +18.4% |
| Q1 FY2018 | Mar 31, 2018 | $19.89B | +16.0% |
| Q4 FY2017 | Dec 31, 2017 | $19.93B | +26.7% |
| Q3 FY2017 | Sep 30, 2017 | $16.23B | – |
| Q2 FY2017 | Jun 30, 2017 | $16.29B | – |
| Q1 FY2017 | Mar 31, 2017 | $17.14B | – |
| Q4 FY2016 | Dec 31, 2016 | $15.73B | – |
See a number that looks wrong?